Survival Outcomes in T3N0 versus N1 in Head and Neck Cutaneous Squamous Cell Carcinoma – Implications for Neoadjuvant Immune Checkpoint Inhibitor Immunotherapy by A.E. Yung, Y.J. Jeong, A.H. Varey, S.N. Lo, R. Gupta, R. Wu, M. Dunn, J.H. Lee, T.-H.H. Low, K.F. Shannon, J.R. Clark, S. Ch'ng

Get full text